** LeMaitre Vascular's LMAT.O shares down 8.5% to $92.10, hit
lowest since Oct 31 early Mon, as medical device co looks to
raise capital
** Burlington, Massachusetts-based implants provider
offering privately $150 mln convertible bonds (CBs) due Feb 2030
** It plans to use net proceeds, including purchase of
additional notes, for general purposes, including potential
acquisitions or investments in complementary companies,
products, or technologies
** Co had ~$2.3 bln market cap as of Fri, per LSEG
** Despite move on the session, stock up ~63% YTD. Shares
hit record intraday high of $109.58 three weeks ago
** Of 10 analysts covering LMAT, 7 rate "strong buy" or
"buy", rest "hold" with $100 median PT - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380 ))